Clinical Trials in Hebei, China
Locations / Hebei, China
Delta Trials records 59 clinical trials conducted in Hebei, China, making it a notable site of clinical research activity. These trials across 82 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Hebei has changed over time.
59
Total Trials
82
Conditions
1
Terminated since 2020
Browse by condition (82 total)
- Asthma 3 trialsAll Asthma trials
- B-cell lymphoma 3 trialsAll B-cell lymphoma trials
- Psoriasis 2 trialsAll Psoriasis trials
- All Chronic obstructive pulmonary disease trials
- Hepatitis b, chronic 2 trialsAll Hepatitis b, chronic trials
- Leptomeningeal metastasis 2 trialsAll Leptomeningeal metastasis trials
- Chronic hcv infection 1 trialAll Chronic hcv infection trials
- Aml, adult 1 trialAll Aml, adult trials
- Treatment resistant depression 1 trialAll Treatment resistant depression trials
- Diabetic macular edema 1 trialAll Diabetic macular edema trials
- Liver diseases 1 trialAll Liver diseases trials
- All Polypoid choroidal vasculopathy (pcv) trials
- Hepatocellular carcinoma 1 trialAll Hepatocellular carcinoma trials
- Mild to moderate depression 1 trialAll Mild to moderate depression trials
- Immune checkpoint inhibitor 1 trialAll Immune checkpoint inhibitor trials
- Headache, migraine 1 trialAll Headache, migraine trials
- Metabolic disorders 1 trialAll Metabolic disorders trials
- Advanced breast cancer 1 trialAll Advanced breast cancer trials
- Dna virus infections 1 trialAll Dna virus infections trials
- All Polypoidal choroidal vasculopathy (pcv) trials